Koree Ramsey
Medical · Chicago, ILNPI 1831620434
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 362 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 34.4% of the total. Reporting peaked in 2022 at $1,695 and has fallen 87.4% since, to $213 in 2025.
Across 362 payments — averaging $14.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- AbbVie$1K
- Gilead$248
- Intercept Pharmaceuticals, Inc.$245
- Ironwood Pharmaceuticals, Inc$205
- QOL Medical, LLC$203
- plus $1K from 20 others
What the payments were for
- Food & beverage$5,225100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 135 | $1,805 |
| AbbVie | 116 | $1,471 |
| Gilead | 16 | $248 |
| Intercept Pharmaceuticals, Inc. | 20 | $245 |
| Ironwood Pharmaceuticals, Inc | 19 | $205 |
| QOL Medical, LLC | 11 | $203 |
| Redhill Biopharma Inc. | 12 | $165 |
| Medtronic | 2 | $125 |
| Bayer | 1 | $125 |
| Johnson & Johnson | 1 | $125 |
| Procept Biorobotics Corporation | 2 | $80 |
| Bristol Myers Squibb | 5 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Lilly USA, LLC | 1 | $35 |
| Amgen | 2 | $33 |
| Ardelyx, Inc. | 2 | $31 |
| Pfizer | 2 | $31 |
| Celltrion USA Inc. | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Vivus LLC | 1 | $16 |
| Sanofi | 1 | $15 |
| Merck | 1 | $15 |
| Pharmacosmos Therapeutics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,244 in reported general payments places this provider in the 85th percentile of 449 medical providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 13 | $141 |
| Ketorolac Tromethamine | 14 | $110 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $110 |
| Ondansetron OdtOndansetron | 15 | $93 |
| Methylprednisolone | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other medical in Chicago
- Andrea TurekChicago$145K
- Jennifer GarsonChicago$32K
- William KvasnickaChicago$19K
- Brittany WolfeChicago$12K
- Eric KingChicago$9K
- Neema ManappuramChicago$8K
- Robert RadtkeChicago$7K
- Justin OkrayChicago$5K
- Alexis DavidmanChicago$5K
- Brittany RankChicago$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.